
Topical non-steroidal medications offer a modern, targeted way to treat Actinic Keratoses the sun-induced “rough spots” that appear on areas like the face, arms, and hands.
With strong anti-inflammatory action, these prescription creams focus directly on abnormal cells while keeping healthy skin protected. At Canberra Skin Cancer Clinic, our dermatology team supports you through every step for safe, effective results.
These medications work at the cellular level to reduce the activity of aberrant cells responsible for Actinic Keratoses. By focusing directly on affected areas, they help prevent the progression of lesions and reduce the risk of more serious skin conditions.
Treatment also addresses subclinical lesions that may not be visible, providing a more comprehensive approach. This ensures that both overt and hidden lesions are treated effectively.


The formulation is carefully balanced to maximize effectiveness while minimizing adverse effects. Most patients experience minimal local reactions, making this a gentle yet potent treatment option.
The treatment regimen typically requires twice-daily application over 60 to 90 days. Our dermatologists provide detailed instructions and monitoring throughout the process to ensure patient comfort and adherence.
Following the treatment period, the skin gradually heals, with lesions resolving and healthy tissue regenerating. Regular follow-ups allow our team to assess results, manage any mild side effects, and provide ongoing guidance for sun protection and skin health.
This structured approach not only treats existing lesions but also supports long-term skin integrity, promoting a smoother, healthier appearance and reducing recurrence risks.

The full course generally lasts 60 to 90 days, depending on the number and size of lesions.
Most patients experience minimal reactions. Mild redness or irritation can occur but is generally short-lived and manageable.
While it treats existing lesions effectively, our dermatologists also provide guidance on sun protection and skin monitoring to reduce the risk of new lesions.
Yes. It is safe for most patients, including those with sensitive skin, when used under professional supervision.
